WN1316

• CAT Number: I038311
• CAS Number: 1356959-71-1
• Molecular Formula: C20H26Cl3N5O
• Molecular Weight: 458.81
• Purity: 98%
• Synonyms: WN1316; WN-1316; WN 1316
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-(5-pyridin-2-yl-1H-imidazol-2-yl)-2-(N,2,4,6-tetramethylanilino)acetamide;trihydrochloride
• InChI: InChI=1S/C20H23N5O.3ClH/c1-13-9-14(2)19(15(3)10-13)25(4)12-18(26)24-20-22-11-17(23-20)16-7-5-6-8-21-16;;;/h5-11H,12H2,1-4H3,(H2,22,23,24,26);3*1H
• InChIKey: XZNHUZDSSZMVLD-UHFFFAOYSA-N
• SMILES: CC1=CC(=C(C(=C1)C)N(C)CC(=O)NC2=NC=C(N2)C3=CC=CC=N3)C.Cl.Cl.Cl

WN1316（Cat No.:I038311）is a small molecule compound that functions as a selective inhibitor of the protein kinase C (PKC) family, specifically targeting the PKC-θ isoform. PKC-θ plays a key role in regulating immune cell activation, particularly in T-cells, and is involved in autoimmune diseases and inflammation. By inhibiting PKC-θ, WN1316 has shown potential in modulating immune responses, making it a candidate for treating autoimmune conditions such as rheumatoid arthritis and psoriasis. It is also being explored for its anti-inflammatory effects in various diseases, although clinical trials are ongoing to assess its safety and efficacy.